Inventor
BIGNER DARELL D
US28 patents
⚠️ This page may combine multiple inventors who share the name “BIGNER DARELL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV DUKE
17 patentsUS5624659AApr 29, 1997
Method of treating brain tumors expressing tenascin
UNIV DUKE144 citations97
US5558852ASep 24, 1996
Methods of treating melanomas and gliomas with monoclonal antibody Me1-14
UNIV DUKE34 citations91
US6503503B1Jan 7, 2003
Allogeneic cellular vaccine
UNIV DUKE20 citations89
US8039593B2Oct 18, 2011
Antibodies and immunotoxins that target human glycoprotein NMB
UNIV DUKE10 citations84
US10799543B2Oct 13, 2020
Oncolytic poliovirus for human tumors
UNIV DUKE4 citations82
US10398743B2Sep 3, 2019
Oncolytic poliovirus for human tumors
UNIV DUKE5 citations82
US11813298B2Nov 14, 2023
Oncolytic poliovirus for human tumors
UNIV DUKE1 citations71
US11406677B2Aug 9, 2022
Oncolytic poliovirus for human tumors
UNIV DUKE3 citations71
US10072084B2Sep 11, 2018
Dual specific immunotoxin for brain tumor therapy
UNIV DUKE2 citations70
US10053514B2Aug 21, 2018
Human bispecific EGFRvIII and CD3 antibody engaging molecules
UNIV DUKE3 citations69
US11506666B2Nov 22, 2022
Detection of CD-155, the poliovirus receptor
UNIV DUKE0 citations59
US11306364B2Apr 19, 2022
TERT promoter mutations in gliomas and a subset of tumors
UNIV DUKE0 citations58
US10711310B2Jul 14, 2020
Tert promoter mutations in gliomas and a subset of tumors
UNIV DUKE1 citations58
US11311628B2Apr 26, 2022
Production of immunotoxin D2C7—(scdsFv)—PE38KDEL
UNIV DUKE1 citations56
US10744170B2Aug 18, 2020
Combination treatment
UNIV DUKE0 citations48
US10744171B2Aug 18, 2020
Sequential anti-cancer treatment
UNIV DUKE0 citations47
US5316932AMay 31, 1994
Homogeneous denatured human 06-guanine alkyltransferase prepared by immunoaffinity chromatography using monoclonal antibody specific for enzyme
UNIV DUKE1 citations42
CORNELL RES FOUNDATION INC
2 patentsUS5695751ADec 9, 1997
Enhancing delivery of large neutral amino acid drugs
CORNELL RES FOUNDATION INC21 citations92
US5523084AJun 4, 1996
Enhancing the anti-tumor effect of melphalan by prior administration of L-amino acid oxidase with or without intermediate administration of anti-L-amino acid oxidase antibody
CORNELL RES FOUNDATION INC3 citations62